Vanguard Group Inc. Sells 826,647 Shares of Agilon Health, Inc. $AGL

Vanguard Group Inc. lowered its stake in shares of Agilon Health, Inc. (NYSE:AGL) by 2.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 30,285,760 shares of the company’s stock after selling 826,647 shares during the quarter. Vanguard Group Inc. owned approximately 7.33% of Agilon Health worth $131,137,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC grew its holdings in Agilon Health by 244.9% during the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock worth $41,000 after acquiring an additional 6,783 shares during the last quarter. Ridgecrest Wealth Partners LLC bought a new position in shares of Agilon Health in the 1st quarter valued at about $65,000. Pallas Capital Advisors LLC bought a new position in shares of Agilon Health in the 1st quarter valued at about $66,000. Humankind Investments LLC bought a new position in shares of Agilon Health in the 4th quarter valued at about $30,000. Finally, KBC Group NV bought a new position in shares of Agilon Health in the 1st quarter valued at about $70,000.

Wall Street Analyst Weigh In

AGL has been the topic of several recent research reports. Benchmark reduced their target price on shares of Agilon Health from $4.00 to $1.50 and set a “buy” rating on the stock in a research note on Wednesday, August 6th. Jefferies Financial Group reduced their target price on shares of Agilon Health from $2.40 to $1.10 and set a “hold” rating on the stock in a research note on Friday, August 15th. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $1.40 target price (down previously from $4.00) on shares of Agilon Health in a research note on Wednesday. The Goldman Sachs Group raised their target price on shares of Agilon Health from $2.50 to $5.00 and gave the company a “neutral” rating in a research note on Thursday, May 8th. Finally, Wells Fargo & Company reduced their target price on shares of Agilon Health from $6.00 to $5.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 13th. Four analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, Agilon Health has an average rating of “Hold” and an average target price of $3.07.

Agilon Health Price Performance

Agilon Health stock opened at $1.2350 on Friday. The company’s 50 day simple moving average is $1.87 and its 200 day simple moving average is $3.00. Agilon Health, Inc. has a fifty-two week low of $0.71 and a fifty-two week high of $6.08. The firm has a market capitalization of $511.81 million, a price-to-earnings ratio of -1.60 and a beta of 0.14.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The firm had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the previous year, the business earned ($0.07) EPS. The firm’s revenue was down 5.9% compared to the same quarter last year. As a group, analysts predict that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.